Abstract
The importance of lung cancer as a complication of lung transplantation is increasingly recognised. It may become an important survival-limiting factor in lung transplant patients as management of other complications continues to improve and utilisation of extended criteria donors grows. Radiology can play a key role in tackling this issue at multiple stages in the transplantation pathway and follow-up process. Routine chest CT as part of pre-transplant recipient assessment (and donor assessment if available) can identify suspicious lung lesions with high sensitivity and detect chronic structural lung diseases such as pulmonary fibrosis associated with an increased risk of malignancy post-transplant. Pre-transplant CT also provides a comparison for later CT studies in the assessment of nodules or masses. The potential role of regular chest CT for lung cancer screening after transplantation is less certain due to limited available evidence on its efficacy. Radiologists should be cognisant of how the causes of pulmonary nodules in lung transplant patients may differ from the general population, vary with time since transplantation and require specific recommendations for further investigation/follow-up as general guidelines are not applicable. As part of the multidisciplinary team, radiology is involved in an aggressive diagnostic and therapeutic management approach for nodular lung lesions after transplant both through follow-up imaging and image-guided tissue sampling. This review provides a comprehensive overview of available clinical data and evidence on lung cancer in lung transplant recipients, and in particular an assessment of the current and potential roles of pre- and post-transplant imaging.
Key Points
• Lung cancer after lung transplantation may become an increasingly important survival-limiting factor as mortality from other complications declines.
• There are a number of important roles for radiology in tackling the issue which include pre-transplant CT and supporting an aggressive multidisciplinary management strategy where lung nodules are detected in transplant patients.
• The introduction of routine surveillance chest CT after transplant in addition to standard clinical follow-up as a means of lung cancer screening should be considered.
Similar content being viewed by others
Abbreviations
- CLAD:
-
Chronic lung allograft dysfunction
- DLT:
-
Double lung transplant
- ECD:
-
Extended criteria donors
- PTLD:
-
Post-transplant lymphoproliferative disorder
- SLT:
-
Single lung transplant
References
Venuta F, Van Raemdonck DE (2017) History of lung transplantation. J Thorac Dis 9:5458–5471. https://doi.org/10.21037/jtd.2017.11.84
Bos S, Vos R, Van Raemdonck DE, Verleden GM (2020) Survival in adult lung transplantation: where are we in 2020? Curr Opin Organ Transplant. 25:268–273. https://doi.org/10.1097/MOT.0000000000000753
Chambers DC, Cherickh WS, Harhay MO et al (2019) The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult lung and heart-lung transplantation report – 2019; focus theme: donor and recipient size match. J Heart Lung Transpl. 38:1042–1055. https://doi.org/10.1016/j.healun.2019.08.001
Villavicencio MA, Axtell AL, Osho A, et al (2018) Single- versus double-lung transplantation in pulmonary fibrosis: impact of age and pulmonary hypertension. Ann Thorac Surg. 106:856–863. https://doi.org/10.1016/j.athoracsur.2018.04.060
Ranganath NK, Malas J, Phillips KG et al (2020) Single and double lung transplantation have equivalent survival for idiopathic pulmonary fibrosis. Ann Thorac Surg. 109:211–217. https://doi.org/10.1016/j.athoracsur.2019.06.090
Chauhan D, Karanam AB, Merlo A et al (2016) Post-transplant survival in idiopathic pulmonary fibrosis patients concurrently listed for single and double lung transplantation. J Heart Lung Transplant. 35:657–660. https://doi.org/10.1016/j.healun.2015.12.030
Li D, Liu Y, Wang B (2020) Single versus bilateral lung transplantation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. PLoS One. 15:e0233732. https://doi.org/10.1371/journal.pone.0233732
Riddell P, Kleinerova J, Eaton D et al (2020) Meaningful survival benefit for single lung transplantation in idiopathic pulmonary fibrosis patients over 65 years of age. Eur Resp J. 56:1902413. https://doi.org/10.1183/13993003.02413-2019
Riddell P, Egan J (2015) International donor conversion rates for lung transplantation need to be standardised. Lancet Respir Med. 3:909–911. https://doi.org/10.1016/S2213-2600(15)00462-2
Christie IG, Chan EG, Ryan JP, Harano T, Morrell M, Luketich JD, Sanchez PG (2021) National trends in extended criteria donor utilization and outcomes for lung transplantation. Ann Thorac Surg. 111:421–426. https://doi.org/10.1016/j.athoracsur.2020.05.087
Bonser RS, Taylor R, Collett D, et al (2012) Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet. 380:747–755. https://doi.org/10.1016/S0140-6736(12)60160-3
Habre C, Soccal PM, Triponez F et al (2018) Radiological findings of complications after lung transplantation. Insights Imaging. 9:709–719. https://doi.org/10.1007/s13244-018-0647-9
Gould MK, Tang T, ILA L et al (2015) Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med. 192:1208–1214. https://doi.org/10.1164/rccm.201505-0990OC
MacMahon H, Naidich DP, Mo Goo J et al (2017) Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. 284:228–243. https://doi.org/10.1148/radiol.2017161659
Bueno J, Landeras L, Chung JH (2018) Updated Fleischner Society Guidelines for managing incidental pulmonary nodules: common questions and challenging scenarios. Radiographics 38:1337–1350. https://doi.org/10.1148/rg.2018180017
Lee P, Minai OA, Mehta AC, DeCamp MM, Murthy S (2004) Pulmonary nodules in lung transplant recipients: etiology and outcome. Chest. 125:165–172. https://doi.org/10.1378/chest.125.1.165
Morla O, Liberge R, Arrigoni PP, Frampas E (2014) Pulmonary nodules and masses in lung transplant recipients: clinical and CT findings. Eur Radiol. 24:2183–2191. https://doi.org/10.1007/s00330-014-3264-0
Collins J, Müller NL, Kazerooni EA, Paciocco G (2000) CT findings of pneumonia after lung transplantation. AJR Am J Roentgenol. 175:811–818. https://doi.org/10.2214/ajr.175.3.1750811
Ng YL, Paul N, Patsios D et al (2009) Imaging of lung transplantation: review. AJR Am J Roentgenol 192(3 Suppl):S1–S19. https://doi.org/10.2214/AJR.07.7061
Krishnam MS, Suh RD, Tomasian A et al (2007) Postoperative complications of lung transplantation: radiologic findings along a time continuum. Radiographics. 27:957–974. https://doi.org/10.1148/rg.274065141
Copp DH, Godwin JD, Kirby KA, Limaye AP (2006) Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipients. Am J Transplant. 6:2759–2764. https://doi.org/10.1111/j.1600-6143.2006.01545.x
Scarsbrook AF, Warakaulle DR, Dattani M, Traill Z (2005) Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances. Clin Radiol. 60:47–55. https://doi.org/10.1016/j.crad.2004.08.016
Bin Saeeden M, Mukhopadhyay S, Randall Lane C, Renapurkar RD (2020) Imaging indications and findings in evaluation of lung transplant graft dysfunction and rejection. Insights Imaging. 11:2. https://doi.org/10.1186/s13244-019-0822-7
Mehta AC, Wang J, Abuqayyas S et al (2016) New nodule-newer etiology. World J Transplant 6:15–219. https://doi.org/10.5500/wjt.v6.i1.215
Wingard JR, Hiemenz JW, Jantz JA (2012) How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation. Blood. 120:1791–1800. https://doi.org/10.1182/blood-2012-02-378976
Bajaj SK, Tombach B (2017) Respiratory infections in immunocompromised patients: lung findings using chest computed tomography. Radiol Inf Dis. 4:29–37. https://doi.org/10.1016/j.jrid.2016.11.001
Chan AW, Fung K, Austin PC et al (2019) Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: population-based cohort study. Am J Transplant 19:522–531. https://doi.org/10.1111/ajt.14966
Engels EA, Pfeiffer RM, Fraumeni JF Jr et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 306:1891–1901. https://doi.org/10.1001/jama.2011.1592
Van Raemdonck D, Vos R, Yserbyt J et al (2016) Lung cancer: a rare indication for, but frequent complication after lung transplantation. J Thorac Dis 8:S915–S924. https://doi.org/10.21037/jtd.2016.11.05
Magruder JT, Crawford TC, Grimm JC et al (2017) Risk factors for de novo malignancy following lung transplantation. Am J Transplant. 17:227–238. https://doi.org/10.1111/ajt.13925
Triplette M, Crothers K, Mahale P et al (2019) Risk of lung cancer in lung transplant recipients in the United States. Am J Transplant. 19:1478–1490. https://doi.org/10.1111/ajt.15181
Collett D, Mumford L, Banner NR, Neuberger J, Watson C (2010) Comparison of the incidence of malignancy in recipients of different types of organ: a UK registry audit. Am J Transplant. 10:1889–1896. https://doi.org/10.1111/j.1600-6143.2010.03181.x
Perez-Callejo D, Torrente M, Parejo C, Laporta R, Ussetti P, Provencio M (2018) Lung cancer in lung transplantation: incidence and outcome. Postgrad Med J. 94:15–19. https://doi.org/10.1136/postgradmedj-2017-134868
Olland ABM, Falcoz PE, Santelmo N, Kessler R, Massard G (2014) Primary lung cancer in lung transplant recipients. Ann Thorac Surg. 98:362–371. https://doi.org/10.1016/j.athoracsur.2014.04.014
Drevet G, Duruisseaux M, Maury JM, et al (2020) Lung cancer surgical treatment after solid organ transplantation: a single-center 30-year experience. Lung Cancer. 139:55–59. https://doi.org/10.1016/j.lungcan.2019.10.023
Shtraichman O, Ahya VN (2020) Malignancy after lung transplantation. Ann Transl Med 8:416. https://doi.org/10.21037/atm.2020.02.126
Raviv, Shitrit D, Amital A et al (2011) Lung cancer in lung transplant recipients: experience of a tertiary hospital and literature review. Lung Cancer. 74:280–283. https://doi.org/10.1016/j.lungcan.2011.02.012
Chen LN, Spivack J, Cao T et al (2020) Characteristics and outcomes of lung cancer in solid organ transplant recipients. Lung Cancer. 146:297–302. https://doi.org/10.1016/j.lungcan.2020.06.018
Raskin J, Vanstapel A, Verbeken EK et al (2020) Mortality after lung transplantation: a single-centre cohort analysis. Transpl Int. 33:130–141. https://doi.org/10.1111/tri.13540
US Preventative Services Taskforce (2021) Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 325:962–970. https://doi.org/10.1001/jama.2021.1117
Acuna SA, Lam W, Daly C, Kim SJ, Baxter NN (2018) Cancer evaluation in the assessment of solid organ transplant candidates: a systematic review of clinical practice guidelines. Transplant Rev (Orlando). 32:29–35. https://doi.org/10.1016/j.trre.2017.10.002
Rosenbaum DH, Bhojani RA, Dikman E et al (2005) Routine computed tomography screening of the chest in high-risk cardiac transplant recipients may improve survival. J Heart Lung Transplant. 24:2043–2047. https://doi.org/10.1016/j.healun.2005.06.020
Mohammadi S, Bonnet N, Leprince P et al (2007) Long-term survival of heart transplant recipients with lung cancer: the role of chest computed tomography screening. Thorac Cardiovasc Surg. 55:438–441. https://doi.org/10.1055/s-2007-965306
Finkenstedt A, Graziadei IW, Oberaigner W et al (2009) Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant patients. Am J Transplant. 9:2355–2361. https://doi.org/10.1111/j.1600-6143.2009.02766.x
Acuna SA, Huang JW, Scott AL et al (2017) Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines. Am J Transplant. 17:103–114. https://doi.org/10.1111/ajt.13978
Grewal AS, Padera RF, Boukedes S et al (2015) Prevalence and outcome of lung cancer in lung transplant recipients. Respir Med. 109:427–433. https://doi.org/10.1016/j.rmed.2014.12.013
Copeland H, Awori Hayanga JW, Neyrinck A et al (2020) Donor heart and lung procurement: a consensus statement. J Heart Lung Transplant 39:501–517. https://doi.org/10.1016/j.healun.2020.03.020
Gauthier JM, Bierhals AJ, Liu J et al (2019) Chest computed tomography imaging improves potential lung donor assessment. J Thorac Cardiovasc Surg 157:1711–1718.e1. https://doi.org/10.1016/j.jtcvs.2018.11.038
National Lung Screening Trial Research Team, Aberle DR, Adams AM et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 365:395–409. https://doi.org/10.1056/NEJMoa1102873
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Carmel Cronin.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained.
Methodology
• retrospective
• single centre
• non-experimental study including literature review and identification of appropriate case examples to support important points
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Delaney, F.T., Murray, J.G., Hutchinson, B.D. et al. The role of radiology in addressing the challenge of lung cancer after lung transplantation. Eur Radiol 32, 8182–8190 (2022). https://doi.org/10.1007/s00330-022-08942-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-022-08942-w